Topical agents and dressings for fungating wounds

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2007, Pages

  Adderley, Una ^a   Smith, R ^b  

^a North Yorkshire and York Primary Care Trust   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RETRACTED ARTICLE; REVIEW;

EID: 44949141485     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003948.pub2     Document Type: Review

References (25)

1. Bower 1992 {published data only} Bower M, Stein R, Evans TR, Hedley A, Pert P, Coombes RC. A double-blind study of the efficacy of metronidazole gel in the treatment of malodorous fungating tumours. European Journal of Cancer 1992;28A(4-5):888-9.
2. Leonard 2001 {published data only} Leonard R, Hardy J, van Tienhoven G, Houston S, Simmonds P, David M, et al.Randomized, double-blind, placebo-controlled, multicenter trial of 6% milefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer. Journal of Clinical Oncology 2001;19(21):4150-9.
3. Bale 2004 Bale S, Tebbie N, Price P. A topical metronidazole gel used to treat malodorous wounds. British Journal of Nursing 2004;13(11):4S-11S.
4. Clive 1999 Clive S, Gardiner J, Leonard RC. Miltefosine as a topical treatment for cutaneous metastases in breast carcinoma. Cancer Chemotherapy Pharmacology 1999;44:29S-30S.
5. Efendiev 1991 Efendiev AI, Tolstykh PI, Dadashev AI, Marshava AM. Topical prolonged enzyme therapy of purulent wounds. Khirurgiia - (Mosk) 1991;91:48-50.
6. Gostishchev 1983 Gostishchev VK, Vasilkova ZF, Khanin AG, Vavilova GS, Lebedskoj AG. Debrisan in the treatment of purulent wounds. Vestnik Chirurgii Imemi Grekova 1983;131(9):56-9.
7. Gostishchev 1985 Gostishchev VK, Tolstykh PI, Khanin AG, Vasilkova ZF, Yusupuv KA, Vlasov, LT, et al.The use of Trypsin immobilised on textile cellulose matrix in the treatment of purulent wounds of soft tissues. Vestnik Chirurgii Imemi Grekova 1985;134(6):68-71.
8. Gostishchev 1993 Gotstishchev VK, Mulyaev LF, Nikolaev AV, Khanin AG, Kassin VY. Regenkur, a polymer sorbent, in the treatment of purulent wounds. Khirurgiya 1993;69(11):3-6.
9. Grocott 2001 Grocott P, Cowley S. The palliative management of fungating malignant wounds - generalising from multiple-case study data using a system of reasoning. International Journal of Nursing Studies 2001;38 (5):533-45.
10. Healy 1969 Healy JB. The use of topical 5-fluorouracil. Journal of the Irish Medical Association 1969;62(380):41-6.
11. Moller 2000 Moller F, Jakobsen V, Jensen K. Performance of Contreet antibacterial hydrocolloid dressing compared to other antibacterial dressings. Tenth Annual Meeting of the European Tissue Repair Society. Brussels: May 2000:24-7.
12. Russell 2001 Russell L, Deeth M, Jones HM, Reynolds T. Vacutex capillary action dressing: a multicentre, randomized trial. British Journal of Nursing 2001;10(11):66S-70S.
13. Stuwe 1983 Stuwe V U. Enzymatische wundreinigung. Fortschritte des Medizin 1983;101(41):1883-8.
14. Taranenko 1984 Taranenko LD, Bondarev VI, Nefedov GP, Shlopov VG, Verkhuletsky IE, Kuznetsov AS. Experience with skin-1K sorbent in the treatment of purulent wounds. Klinichna Khirurhiia 1984:44-7.
15. Upright 1994 Upright CA, Salton C, Roberts F, Murphy J. Evaluation of Mesalt dressings and continuous wet saline dressings in ulcerating metastatic skin lesions. Cancer Nursing 1994;17:149-55.
16. Bale 1991 Bale S, Harding K. Fungating Breast Wounds. Journal of District Nursing 1991;9(12):4-5.
17. Bridel-Nixon 1997 Bridel-Nixon J. Other Chronic Wounds. In: MorisonM, MoffattC, Bridel-NixonJ, BaleS editor(s). Nursing Management of Chronic Wounds. 1st Edition. London: Mosby, 1997:221-45.
18. Fairburn 1994 Fairburn K. A challenge that requires further research. Management of fungating breast lesions. Professional Nurse 1994;9:272-7.
19. Grocott 1995 Grocott P. The palliative management of fungating malignant wounds. Journal of Wound Care 1995;4(5):240-2.
20. Grocott 2001a Grocott P. Developing a tool for researching fungating wounds. World Wide Wounds (online) 2001; Vol. available at http://www.worldwidewounds.com/2001/July/Grocott/Fungating-Wounds.html, issue Accessed 12 October 2001.
21. Grocott 2002 Grocott P. A review of advances in fungating wound management since EWMA 1991. European Wound Management Association Journal 2002;2(1):21-4.
22. Hirst 1992 Hirst DG. Tumour Vascular Physiology. Annual report of the Cancer Research Campaign Grey Laboratory 1992.
23. Kelly 2002 Kelly N. Malodorous fungating wounds: a review of current literature. Professional Nurse 2002;17(5):323-6.
24. Stotter 1991 Stotter A, Kroll S, McNeese M, Holmes F, Oswald MJ, Romsdahl M. Salvage treatment for loco-regional recurrence following breast conservation therapy for early breast cancer. European Journal of Surgical Oncology 1991;17:231-6.
25. WHO 1979 World Health Organisation. WHO Handbook for Reporting Results of Cancer Treatment. Geneva: World Health Organisation, 1979.